Atea Pharmaceuticals (AVIR) Earnings Date & Reports

Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

AVIR is expected to report earnings to rise 32.93% to -54 cents per share on November 05

Atea Pharmaceuticals AVIR Stock Earnings Reports

Q3'26

Est.

$-0.55

Q2'26

Beat

by $0.15

Q1'26

Missed

by $0.01

Q4'25

Missed

by $0.13

Q3'25

Missed

by $0.11

The last earnings report on August 12 showed earnings per share of -40 cents, beating the estimate of -56 cents. With 149.88K shares outstanding, the current market capitalization sits at 413.86M.

View a ticker or compare two or three

AVIR

Daily Signal:

Gain/Loss:

Swing Trader for Large Caps: Focusing on Intrinsic Value Metrics, 60 min, (FA)Swing Trader for Large Caps: Focusing on Intrinsic Value Metrics, 60 min, (FA)

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

Interact to see
Advertisement